13F data as of 2025-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/GLYCEUR

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

38000Q102

FAQ

Who are the top institutional investors holding GLYCOMIMETICS INC (GLYCEUR)?

Major stakeholders currently include Bvf Inc/il ($2.0M), Logos Global Management LP ($1.1M), Adage Capital Partners Gp, L.l.c. ($1.1M). Based on the latest 13F filings, there are a total of 37 tracked investment funds and institutions maintaining positions in GLYCEUR.

What is the overall institutional sentiment toward GLYCEUR recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $1.1M, driven by 28 managers accumulating shares while 10 reduced their exposure.

Which institutions have been selling or reducing their GLYCEUR positions?

In the latest period, 2 funds trimmed their holdings, and 8 managers completely exited their positions. The aggregate reported sell value was $3.8M.

Are there any notable investors adding GLYCEUR to their portfolios?

Yes, buying activity remains notable. 27 institutions opened new positions in {ticker}, and 1 existing holders added to their shares. The total reported buy value for the quarter amounted to $4.3M.